Handelsavisen
prelaunch
Companies Healthcare 1518.HK
15
1518.HK HKEX Healthcare Facilities & Services

New Century Healthcare Holding Co Ltd

HK$0,55
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

New Century Healthcare Holding Co Ltd operates in the healthcare facilities and services industry, providing pharmaceutical and healthcare-related services to its customers.

Business. New Century Healthcare Holding Co Ltd (1518.HK) is a healthcare services and equipment company primarily engaged in pharmaceutical activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Hong Kong, the company is listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments and geographic presence are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 1518.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 1518.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    New Century Healthcare Holding Co Ltd (1518.HK) is a healthcare services and equipment company primarily engaged in pharmaceutical activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Hong Kong, the company is listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments and geographic presence are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    New Century Healthcare Holding Co Ltd has a basic and diluted share count of 490,025,000 shares, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.

    The company reported a negative earnings per share (EPS) of -0.22 CNY, suggesting a loss in the most recent reporting period. This performance is below the industry median for profitability metrics, indicating potential challenges in maintaining profitability relative to its peers.

    The company's revenue for the latest period was 512,785,000 CNY. While the company operates in the healthcare sector, the data does not provide a breakdown of revenue by geographic region or business segment, limiting the ability to assess exposure to specific markets or product lines.

    The company's growth trajectory is unclear, as the outlook for the current and next fiscal years is not provided in the available data. The absence of forward-looking guidance makes it difficult to assess the company's growth potential or strategic direction.

    The risk assessment indicates a low dilution risk, but the liquidity risk remains unassessed due to the lack of balance-sheet data and no going-concern language in the source documents. This uncertainty could affect the company's ability to meet short-term obligations.

    No recent events, such as filings or transcripts, are available in the provided data to inform the company's current strategic or operational developments.

    Key takeaways
    • New Century Healthcare Holding Co Ltd has a basic and diluted share count of 490,025,000 shares, indicating no immediate dilution pressure.
    • The company reported a negative EPS of -0.22 CNY, suggesting a loss in the most recent reporting period.
    • The company's revenue for the latest period was 512,785,000 CNY.
    • The liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2021-03-31
    FY 2021 · Full-year highlights

    Revenue ¥600.1M, −29,1% YoY; Operating income −150,0% YoY.

    Revenue¥600.1M−29,1 % YoY
    Operating income-¥71.0M−150,0 % YoY
    Net income-¥115.3M−343,4 % YoY
    Free cash flow-¥71.9M−167,1 % YoY
    EPS
    Operating cash flow¥17.9M−86,8 % YoY
    Financials
    Income statement
    Revenue¥600.1M
    Gross profit¥175.9M
    Operating income-¥71.0M
    Net income-¥115.3M
    Margins
    Gross margin29.3%
    Operating margin-11.8%
    Net margin-19.2%
    FCF margin-12.0%
    Balance sheet
    Total assets¥745.3M
    Total liabilities¥316.5M
    Total equity¥428.8M
    Cash & equivalents
    Long-term debt¥166.2M
    Cash flow
    Operating cash flow¥17.9M
    CapEx-¥9.6M
    Free cash flow-¥71.9M
    SBC
    P&L flow · revenue → net income
    Revenue ¥600.1MOperating costs ¥671.1MTax ¥44.3MNet income ¥115.3M
    Highlights
    • Revenue ¥600.1M, −29,1% YoY
    • Operating income −150,0% YoY
    • Net income −343,4% YoY
    • Free cash flow −167,1% YoY
    • Net margin -19.2%

    Valuation FY

    Market price
    HK$0,55
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • New Century Healthcare Holding Co Ltd Market data — financials · 2026-05-26
    • New Century Healthcare Holding Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    1518.HKCanonical
    HKEX · HKD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2021-03-31 20:32 UTCEARNINGSAnnual results — FY 2021 Revenue CNY 600.1M · Net CNY -115.3M
    2018-03-28 20:27 UTCEARNINGSAnnual results — FY 2018 Revenue CNY 636.5M · Net CNY -297.7M
    2017-03-28 20:35 UTCEARNINGSAnnual results — FY 2017 Revenue CNY 632.6M · Net CNY -101.5M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage